Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
KAPAthis companyKairos Pharma, Ltd.	$0.49	-2.37×	2.06×	0×	-1.63×	209.1%	0.0%	0.0%	0.0%	-85.9%	-87.9%	-26.3%	0×	0.85×	0×	27.07×	0.0%	2	-4.85	2	C+
ALLRAllarity Therapeutics, Inc.	$0.97	-1.38×	1.58×	48.53×	-0.2×	20.0%	100.0%	-3939.1%	-3509.7%	-114.3%	-112.3%	-95.5%	0.14×	1.2×	-68.14×	2.13×	0.0%	1	-6.62	1	C-
CINGCingulate Inc.	$4.40	-1.05×	9.4×	0×	-1.1×	-99.0%	0.0%	0.0%	0.0%	-894.8%	-176.5%	-73.8%	3.5×	0.11×	-21.57×	1.16×	0.0%	2	-3.41	2	C
PTHSPelthos Therapeutics Inc.	$9.27	-1.35×	1.5×	3.47×	-1.65×	872.0%	44.2%	-193.1%	-257.9%	-111.4%	-26.4%	-38.9%	0.9×	-0.37×	-10.77×	2.03×	0.0%	4	-2.04	2	B-
PULMPulmatrix, Inc.	$1.39	-1.58×	2.14×	0×	-0.79×	-24.7%	0.0%	0.0%	0.0%	-135.5%	-135.7%	-66.7%	0×	0.79×	0×	12.55×	0.0%	1	-130.04	2	C
Peer median	—	-1.37×	1.86×	1.74×	-0.94×	-2.4%	22.1%	-96.5%	-129.0%	-124.9%	-124.0%	-70.3%	0.52×	0.45×	-16.17×	2.08×	0.0%	2	-5.02	2	—